Home > Home > Notice > 正文

Notice

【Scientific Research Achievements】 Sulfoconjugation of protein peptides and glycoproteins in physiology and diseases

sources: time:2023-10-06 views:

Sulfoconjugation of protein peptides and glycoproteins in physiology and diseases

Pengfei Xu a b, Xinran Cai a, Xiuchen Guan c, Wen Xie

Pharmacology & Therapeutics 2023

doi.org/10.1016/j.pharmthera.2023.108540

Abstract

Protein sulfoconjugation, or sulfation, represents a critical post-translational modification (PTM) process that involves the attachment of sulfate groups to various positions of substrates within the protein peptides or glycoproteins. This process plays a dynamic and complex role in many physiological and pathological processes. Here, we summarize the importance of sulfation in the fields of oncology, virology, drug-induced liver injury (DILI), inflammatory bowel disease (IBD), and atherosclerosis. In oncology, sulfation is involved in tumor initiation, progression, and migration. In virology, sulfation influences viral entry, replication, and host immune response. In DILI, sulfation is associated with the incidence of DILI, where altered sulfation affects drug metabolism and toxicity. In IBD, dysregulation of sulfation compromises mucosal barrier and immune response. In atherosclerosis, sulfation influences the development of atherosclerosis by modulating the accumulation of lipoprotein, and the inflammation, proliferation, and migration of smooth muscle cells. The current review underscores the importance of further research to unravel the underlying mechanisms and therapeutic potential of targeting sulfoconjugation in various diseases. A better understanding of sulfation could facilitate the emergence of innovative diagnostic or therapeutic strategies.


分享到: